Table 1. Clinical characteristics, causes of death, and DST results of patients with early and late death during ATT.
Variables | Early death (n = 36) | Late death (n = 38) | P value |
---|---|---|---|
Age, yr | 78 (71–85) | 76 (71–83) | 0.327 |
Age > 70 yr, No. (%) | 28 (78) | 30 (79) | 0.903 |
Male, No. (%) | 26 (72) | 25 (66) | 0.550 |
Low BMI (< 18.5 kg/m2), No. (%) | 12 (33) | 9 (24) | 0.357 |
Prior TB history, No. (%) | 3 (8) | 5 (13) | 0.712 |
Comorbidities, No. (%) | |||
None | 12 (33) | 10 (26) | 0.509 |
Diabetes mellitus | 10 (28) | 8 (21) | 0.500 |
Chronic heart disease | 5 (14) | 6 (16) | 0.818 |
Chronic lung disease | 5 (14) | 1 (3) | 0.103 |
Chronic liver disease | 5 (11) | 1 (3) | 0.103 |
Chronic kidney disease | 2 (6) | 5 (13) | 0.431 |
Neurologic disease | 3 (8) | 1 (3) | 0.351 |
Malignancy | 4 (11) | 15 (40) | 0.005 |
Anemia (male < 13 g/dL, female < 12 g/dL), No. (%) | 28 (78) | 29 (76) | 0.881 |
Site of TB, No. (%) | 0.602 | ||
Pulmonary alone | 29 (81) | 31 (82) | |
Pulmonary + extrapulmonary | 6 (17) | 4 (11) | |
Extrapulmonary alone | 1 (3) | 3 (8) | |
Severe degree of pul-TB on chest X-ray, No. (%) | 19 (53) | 12 (32) | 0.065 |
Smear-positive sputum, No. (%) | 19/34 (56) | 20/32 (63) | 0.585 |
Time from presentation to hospital to ATT, day | 1 (1–3) | 5 (1–14) | < 0.001 |
Time from ATT to death, day | 21 (7–38) | 131 (99–226) | < 0.001 |
DST to first-line drugs, No. (%) | 0.707 | ||
All sensitive | 30 (83) | 32/37 (86) | - |
Any resistance | 6 (17) | 5/37 (14) | 1.000 |
Isoniazid resistance | 4 (11) | 5/37 (14) | 0.240 |
Multi-drugs resistance | 2 (6) | 0/37 (0) | - |
Cause of death | < 0.001 | ||
TB-related | 20 (56) | 4 (11) | |
TB-unrelated | 16 (44) | 34 (89) |
BMI = body mass index, TB = tuberculosis, pul-TB = pulmonary tuberculosis, ATT = anti-tuberculosis treatment, DST = drug susceptibility test, IQR = interquartile range.